Anthony Gregg Lapointe Rigel Pharmaceuticals Inc (RIGL) insider trading activity

Anthony Gregg Lapointe is of RIGEL PHARMACEUTICALS INC. Currently has a direct ownership of 12,500 shares of RIGL, which is worth approximately $235,750. The most recent transaction as insider was on May 23, 2025, when has been sold 2,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.5K

87.5% 3M change

87.5% 12M change

Total Value Held $235,750

ANTHONY GREGG LAPOINTE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2025	BUY Grant, award, or other acquisition	-	2,500 Added 16.67%	12,500 Common Stock
May 25 2024	BUY Grant, award, or other acquisition	-	25,000 Added 20.0%	100,000 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	25,000 Added 25.0%	75,000 Common Stock
May 20 2022	BUY Grant, award, or other acquisition	-	25,000 Added 33.33%	50,000 Common Stock
May 19 2021	BUY Grant, award, or other acquisition	-	25,000 Added 50.0%	25,000 Common Stock

Also insider at

ATXS

Astria Therapeutics, Inc. Healthcare

Director

SNGX

SOLIGENIX, INC. Healthcare

AGL